Miyake Y, Tajima S, Funahashi T, Yamamoto A
Department of Etiology and Pathophysiology, National Cardiovascular Center Research Institute, Osaka, Japan.
J Biol Chem. 1989 Oct 5;264(28):16584-90.
A mutant low density lipoprotein (LDL) receptor with abnormal ligand binding and recycling abilities was found in a patient with familial hypercholesterolemia. The molecular weights of the precursor and the mature form of the receptor were 72,000 and 115,000, respectively, which were about 45,000 smaller than those of the normal receptor. The mutant receptor was concluded to be present on the cell surface because the mature form was susceptible to Pronase digestion, and specific monoclonal antibody against the LDL receptor (IgG-C7) could bind to the cell surface. This mutant receptor could not bind LDL, but could bind other ligands for the LDL receptor, beta-migrating very low density lipoprotein, and the apolipoprotein E-lipid complex. After the receptor bound to the ligand, it disappeared from the cell surface of the mutant cells faster than that of normal cells, showing that, in the mutant cells, the receptor was not efficiently recycled back to the cell surface. Southern blotting of the genomic DNA from the patient showed a large deletion of about 12 kilobases around the epidermal growth factor precursor homology domain. For further characterization of the mutant, we cloned a 9.4-kilobase EcoRI/XbaI fragment, which was expected to contain the deletion joint. Mapping and sequencing analyses of the receptor gene showed that exons 7-14 were deleted. The nucleotide sequence suggested that this mutation may have occurred by recombination between repetitive Alu sequences in introns 6 and 14 of the receptor gene. The recombination brought about a complete deletion of the gene coding the epidermal growth factor precursor homology domain. The characteristics of the receptor protein produced by this mutation were similar to those of an artificial mutation constructed by Davis et al. (Davis, C. G., Goldstein, J. L., Südhof, T. C., Anderson, R. G. W., Russell, D. W., and Brown, M. S. (1987) Nature 326, 760-765) in which the whole gene coding this domain was deleted. The clinical phenotype of the patient having this mutation was similar to that of so-called "receptor-defective" type familial hypercholesterolemia, in which cells show detectable, but markedly reduced activity of the LDL receptor.
在一名家族性高胆固醇血症患者中发现了一种具有异常配体结合和循环能力的突变型低密度脂蛋白(LDL)受体。该受体前体和成熟形式的分子量分别为72,000和115,000,比正常受体的分子量小约45,000。由于成熟形式易受链霉蛋白酶消化,且抗LDL受体的特异性单克隆抗体(IgG-C7)可与细胞表面结合,因此得出该突变受体存在于细胞表面的结论。这种突变受体不能结合LDL,但能结合LDL受体的其他配体、β-迁移极低密度脂蛋白和载脂蛋白E-脂质复合物。受体与配体结合后,它从突变细胞的细胞表面消失的速度比正常细胞快,这表明在突变细胞中,受体不能有效地循环回到细胞表面。对该患者基因组DNA进行Southern印迹分析显示,在表皮生长因子前体同源结构域周围有大约12千碱基的大片段缺失。为了进一步表征该突变体,我们克隆了一个9.4千碱基的EcoRI/XbaI片段,预计该片段包含缺失接头。对受体基因的定位和测序分析表明,外显子7-14缺失。核苷酸序列表明,这种突变可能是由受体基因内含子6和14中的重复Alu序列之间的重组引起的。这种重组导致编码表皮生长因子前体同源结构域的基因完全缺失。由这种突变产生的受体蛋白的特征与Davis等人构建的人工突变体(Davis, C. G., Goldstein, J. L., Südhof, T. C., Anderson, R. G. W., Russell, D. W., and Brown, M. S. (1987) Nature 326, 760-765)相似,在该人工突变体中,编码该结构域的整个基因被删除。具有这种突变的患者的临床表型与所谓的“受体缺陷型”家族性高胆固醇血症相似,在这种疾病中,细胞显示出可检测到但明显降低的LDL受体活性。